Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City
Background: Antimalarial drugs were widely used as experimental therapies against COVID-19 in the initial stages of the pandemic. Despite multiple randomized controlled trials demonstrating unfavorable outcomes in both efficacy and adverse effects, antimalarial drugs are still prescribed in developi...
Main Authors: | Oscar Arturo Lozano-Cruz, José Víctor Jiménez, Antonio Olivas-Martinez, Edgar Ortiz-Brizuela, José Luis Cárdenas-Fragoso, Daniel Azamar-Llamas, Sergio Rodríguez-Rodríguez, Jorge Carlos Oseguera-Moguel, Joel Dorantes-García, Clemente Barrón-Magdaleno, Aldo C Cázares-Diazleal, Carla Marina Román-Montes, Karla María Tamez-Torres, Bernardo Alfonso Martínez-Guerra, Alfonso Gulias-Herrero, María Fernanda González-Lara, Alfredo Ponce-de-León-Garduño, David Kershenobich-Stalnikowitz, José Sifuentes-Osornio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.668678/full |
Similar Items
-
Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given
by: Amit Malviya
Published: (2020-03-01) -
Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01) -
Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2020-12-01) -
Chloroquine-Based Mitochondrial ATP Inhibitors
by: Zhiguo Wang, et al.
Published: (2023-01-01) -
New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine
by: Davide Gentile, et al.
Published: (2020-08-01)